المؤلفون: Peter Elsner, Cornelia Mauch, Lisa Zimmer, Mareike Alter, Alexander Enk, Friedegund Meier, Matthias Goebeler, Verena Müller, Mirjana Ziemer, Konstantin Drexler, Claudia Pföhler, Sebastian Haferkamp, Jessica C. Hassel, Christiane Bayerl, Katharina C. Kähler, Markus Zutt, Markus Streit, Nicole Kreuzberg, Thomas Tüting, Patrick Terheyden, Christiane Pfeiffer, Carmen Loquai, Dirk Debus, Nina Devereux, Ahn Van Nguyen, Elisabeth Livingstone, Rainer Rompel, Christian Posch, Steffen Emmert, Ulrich Wesselmann, Evelyn Dabrowski, Matthias Schmuth, Max Schlaak, Anja Wessely, Christoffer Gebhardt, Anja Gesierich, Gesina Hansel, Theresa Steeb, Uwe Wollina, Julia Welzel, Erwin S. Schultz, Reinhard Dummer, Jan C. Simon, Hans-Joachim Schulze, Ralf Gutzmer, Michael Max Sachse, Rose K. C. Moritz, Steven Goetze, J. Mangana, Lara Valeska Maul, Markus V. Heppt, Harald Löffler, Kjell M. Kaume, Wolfgang Krapf, Percy Lehmann, Carola Berking, Stefanie Sauder, Alexander A. Navarini, Edgar Dippel, Bastian Schilling, Markus Meissner, Alexander Thiem, Dirk Schadendorf, Pia Dücker, Sergij Goerdt, Gerhard Weyandt, Lucie Heinzerling, Kerstin Schatton, Erika Richtig, Guido Bruning, Armin Bender, Peter Mohr

المصدر: Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Uveal Neoplasms, 0301 basic medicine, Cancer Research, Skin Neoplasms, Cross-sectional study, Original Article – Clinical Oncology, Patterns of care, Medizin, Aftercare, Disease, German, Uveal melanoma, 0302 clinical medicine, Germany, Surveys and Questionnaires, Mass Screening, Neoplasm Metastasis, Practice Patterns, Physicians', Melanoma, Referral and Consultation, Treatment patterns, Surveillance, Follow-up, Ocular melanoma, General Medicine, ddc, Oncology, Austria, Population Surveillance, 030220 oncology & carcinogenesis, language, Switzerland, medicine.medical_specialty, Ocular Melanoma, 03 medical and health sciences, medicine, Humans, ddc:610, Monitoring, Physiologic, Health Services Needs and Demand, business.industry, Cancer, Guideline, medicine.disease, language.human_language, Background, Cross-Sectional Studies, 030104 developmental biology, Family medicine, Neoplasm Recurrence, Local, Skin cancer, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ac1f0180e423fc3060e58286fbdaa6Test
https://doi.org/10.1007/s00432-020-03450-0Test

المؤلفون: Philip Friedlander, Claudia Pföhler, Michael Max Sachse, Max Schlaak, Carola Berking, Lavinia Spain, Alexander M. Menzies, Friedegund Meier, Rafaela Kramer, Kinan Hayani, Céleste Lebbé, Katharina C. Kähler, Lisa Zimmer, Milena Dudda, Anne Zaremba, Alvaro Moreira, Jessica C. Hassel, Georgina V. Long, Barouyr Baroudjian, Lydia Reinhardt, Alison Weppler, Adriana Hepner, Matteo S. Carlino, Carmen Loquai, Paul J Bröckelmann, Anja Gesierich, Tomohiro Enokida, Douglas B. Johnson, Lucie Heinzerling, Thomas Eigentler, Makoto Tahara, Martin Salzmann, Selma Ugurel

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Neutropenia, medicine.medical_treatment, Medizin, medicine.disease_cause, Gastroenterology, Autoimmunity, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Immune system, Adrenal Cortex Hormones, Internal medicine, medicine, Humans, Adverse effect, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Hemophagocytic lymphohistiocytosis, business.industry, Incidence, Incidence (epidemiology), Cancer, Anemia, Immunosuppression, Middle Aged, medicine.disease, Thrombocytopenia, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business, Immunosuppressive Agents

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbea5c242e2582a869d1911e0b68e0cdTest
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85102118984Test

المؤلفون: Julia K. Tietze, Ralf Gutzmer, Claus Garbe, Lucie Heinzerling, Jessica C. Hassel, Anja Gesierich, Andrea Forschner, Friedegund Meier, Michael C. Kirchberger, Lisa Zimmer, Carmen Loquai, Ursula Dietrich, Carsten Weishaupt, Reinhard Dummer, Ioannis Thomas, Renate Ursula Wahl, Simone M. Goldinger, Martin Leverkus, Dirk Schadendorf, Carola Berking, Jochen Utikal, Thomas Eigentler, Angela M. Krackhardt, Lars Hofmann, Daniela Göppner, Selma Ugurel, Gerold Schuler, Maria I. Schmidgen

المساهمون: University of Zurich, Heinzerling, Lucie M

المصدر: European Journal of Cancer. 60:210-225

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Eye Diseases, Heart Diseases, Programmed Cell Death 1 Receptor, Respiratory Tract Diseases, Medizin, 610 Medicine & health, Antineoplastic Agents, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, 1306 Cancer Research, Musculoskeletal Diseases, Adverse effect, Melanoma, Aged, Retrospective Studies, business.industry, 10177 Dermatology Clinic, Antibodies, Monoclonal, Cancer, Cell Cycle Checkpoints, Middle Aged, medicine.disease, Myasthenia gravis, Nivolumab, 030220 oncology & carcinogenesis, Immunology, 2730 Oncology, Female, Nervous System Diseases, Skin cancer, business, 030217 neurology & neurosurgery, medicine.drug

وصف الملف: 657_Zimmer L. et al._Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD1 Therapy_EJC 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1556fdca6ff1cf1a91650c07c15aefTest
https://doi.org/10.1016/j.ejca.2016.02.024Test

المؤلفون: Jörg Trojan, Lucie Heinzerling, Victor Grünwald, Lisa Zimmer, Niels Reinmuth, Marc-Oliver Grimm, Oliver Bähr, Jessica C. Hassel, Thomas Eigentler, Jan Leipe, Ralf Gutzmer, Julia K. Tietze, Jens Aberle

المصدر: Cancer treatment reviews. 57

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, CTLA-4 Antigen, Melanoma, business.industry, Cancer, Antibodies, Monoclonal, General Medicine, Immunotherapy, medicine.disease, Immune checkpoint, Blockade, 030104 developmental biology, Nivolumab, Methylprednisolone, 030220 oncology & carcinogenesis, business, Adverse drug reaction, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ec2049804c88f517be79f732e117cbTest
https://pubmed.ncbi.nlm.nih.gov/28550712Test

المؤلفون: Jochen Utikal, Jessica C. Hassel, Daniela Göppner, Martin Leverkus, Maria I. Schmidgen, Reinhard Dummer, Thomas Eigentler, Carola Berking, Anja Gesierich, Lisa Zimmer, Ursula Dietrich, Andrea Forschner, Angela M. Krackhardt, Friedegund Meier, Gerold Schuler, Carsten Weishaupt, Ioannis Thomas, Simone M. Goldinger, Ralf Gutzmer, Claus Garbe, Selma Ugurel, Dirk Schadendorf, Carmen Loquai, Lars Hofmann, Lucie Heinzerling, Renate Ursula Wahl, Julia K. Tietze, Michael C. Kirchberger

المصدر: European journal of cancer (Oxford, England : 1990). 60

مصطلحات موضوعية: 0301 basic medicine, Adult, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Gastrointestinal Diseases, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Antineoplastic Agents, Pembrolizumab, Antibodies, Monoclonal, Humanized, Endocrine System Diseases, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Endocrine system, Medicine, Humans, Melanoma, Aged, Retrospective Studies, Gastrointestinal tract, business.industry, Cancer, Antibodies, Monoclonal, Middle Aged, medicine.disease, 030104 developmental biology, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Immunology, Female, Kidney Diseases, Drug Eruptions, Skin cancer, Chemical and Drug Induced Liver Injury, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263bce5158d70c2cbeead10f02368ef9Test
https://pubmed.ncbi.nlm.nih.gov/27085692Test

المؤلفون: Phillip Wong, Dirk Schadendorf, Christian U. Blank, Antje Sucker, Bastian Schilling, Thomas Eigentler, Jianda Yuan, Emanuela Romano, Alexander Martens, Marnix H Geukes Foppen, Kilian Wistuba-Hamprecht, Mariaelena Capone, Jedd D. Wolchok, Graham Pawelec, Brigitte Dréno, Claus Garbe, Amir Khammari, Peter Martus, Anna Maria Di Giacomo, Jessica C. Hassel, Michael A. Postow, Paolo A. Ascierto, Benjamin Weide, Michele Maio

المساهمون: Department of Internal Medicine II, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen-Center for Medical Research, University of Tübingen, Department of Dermatology [Tubingen, Germany], Tübingen University Hospital [Germany], The Netherlands Cancer Institute, Memorial Sloane Kettering Cancer Center [New York], Weill Medical College of Cornell University [New York], Immunité et cancer (U932), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de dermatologie [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), Department of Dermatology, University Hospital Essen, Fondazione IRCCS Istituto Nazionale dei Tumori, Division of Medical Oncology and Immunotherapy, University Hospital of Siena, German Cancer Consortium, Heidelberg University Hospital [Heidelberg], Department of Immunology [Tübingen, Germany], Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Bernardo, Elizabeth, University of Tübingen [Germany], Eberhard Karls Universität Tübingen-Center for Medical Research, Memorial Sloan Kettering Cancer Center ( MSKCC ), Immunité et cancer ( U932 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut Curie-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université de Nantes ( UN ) -Centre hospitalier universitaire de Nantes ( CHU Nantes ), Centre de Recherche en Cancérologie / Nantes - Angers ( CRCNA ), CHU Angers-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Hôpital Laennec-Centre National de la Recherche Scientifique ( CNRS ) -Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes ( CHU Nantes )

المصدر: Clinical Cancer Research
Clinical Cancer Research, 2016, 22, pp.2908-2918. ⟨10.1158/1078-0432.CCR-15-2412⟩
Clinical Cancer Research, American Association for Cancer Research, 2016, 22, pp.2908-2918. ⟨10.1158/1078-0432.CCR-15-2412⟩
Clinical Cancer Research, American Association for Cancer Research, 2016, 22, pp.2908-2918. 〈10.1158/1078-0432.CCR-15-2412〉

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Lymphocyte, Medizin, Ipilimumab, [SDV.CAN]Life Sciences [q-bio]/Cancer, T-Lymphocytes, Regulatory, Article, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Biomarkers, Tumor, medicine, Humans, Lymphocyte Count, IL-2 receptor, Adverse effect, Melanoma, Aged, L-Lactate Dehydrogenase, Proportional hazards model, business.industry, Myeloid-Derived Suppressor Cells, FOXP3, Cancer, medicine.disease, 3. Good health, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Immunology, Erythrocyte Count, Biomarker (medicine), Female, business, 030215 immunology, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::111624c551f34899ca59eea550dc6d4cTest
https://www.hal.inserm.fr/inserm-01409624/file/2016Art18Eq2.pdfTest